Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Lee (Seoul, Republic of Korea), D. Lee (Seoul, Republic of Korea), S. Wi (Seoul, Republic of Korea), S. Lim (Seoul, Republic of Korea), H. Park (Seoul, Republic of Korea). Blood eosinophil as a treatable trait in patients with bronchiectasis. 2405

Member's Comments

No comment yet.

Related content which might interest you: Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease Source: Eur Respir J 2016; 47:1299-1303 Year: 2016 Blood eosinophil count and exacerbation risk in patients with COPD Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017 Year: 2017 Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018 Year: 2018 Blood eosinophils and obstructive lung disease in the general population Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS) Year: 2018 Blood eosinophil as a biomarker in COPD Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma Source: Annual Congress 2013 –Asthma Year: 2013 Blood eosinophilia in patients with COPD, a real life evaluation Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Sputum analysis reveals eosinophilic inflammation in difficult-to-control asthma patients with low blood eosinophils and FENO. Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 FENO and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Correlation between sputum and blood eosinophils in asthmatic and COPD patients with comorbidities. Source: International Congress 2018 – Airway disease: recent discoveries Year: 2018 Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Relationship of blood eosinophil count to exacerbations in asthma patients with a COPD diagnosis Source: International Congress 2015 – Epidemiological studies of asthma and allergy Year: 2015 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Blood eosinophil count to predict bronchial eosinophilic inflammation in COPD Source: Eur Respir J 2016; 47:1562-1564 Year: 2016 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Interpreting blood eosinophil counts in health and obstructive lung disease Source: Eur Respir J, 59 (1) 2102180; 10.1183/13993003.02180-2021 Year: 2022